Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 3, 2026 20:03 UTC |
Noor JehanzebSee remarks below.
|
Exercise / conversionCommon Stock | 6,626 | $0.00 | $0.00 |
DisclosureSEC source: 0002059755-26-000004 · form4-04032026_080411.xml · nonDerivative · entry 1 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 202 shares acquired under the Employee Stock Purchase Plan on December 31, 2025. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:20 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 182.421 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001745891-26-000002 · form4-04022026_080434.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,391.591 Underlying: Common Stock · 182.421 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 18.122 phantom stock units accrued on July 31, 2025, 17.223 phantom stock units accrued on October 31, 2025, and 20.035 phantom stock units accrued January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:19 UTC |
Kolli SreelakshmiDirector
|
GrantPhantom Stock Units · Derivative | 175.404 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001689392-26-000004 · form4-04022026_080441.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,769.994 Underlying: Common Stock · 175.404 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1 F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 15.067 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:18 UTC |
Shapiro LouisDirector
|
GrantPhantom Stock Units · Derivative | 154.356 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001999146-26-000004 · form4-04022026_080444.xml · derivative · entry 1 Shapiro Louis · CIK 0001999146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,661.254 Underlying: Common Stock · 154.356 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 6.544 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:17 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 378.873 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001587868-26-000006 · form4-04022026_080452.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,684.719 Underlying: Common Stock · 378.873 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 30.381 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:17 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 308.711 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001142083-26-000004 · form4-04022026_080403.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,375.195 Underlying: Common Stock · 308.711 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 99.385 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:16 UTC |
Kurdikar DevdattDirector
|
GrantPhantom Stock Units · Derivative | 154.356 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001910621-26-000004 · form4-04022026_080411.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,928.847 Underlying: Common Stock · 154.356 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 4.508 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:15 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 308.711 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001222676-26-000004 · form4-04022026_080412.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,982.841 Underlying: Common Stock · 308.711 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 87.178 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:13 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 420.97 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001485164-26-000004 · form4-04022026_080452.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,245.033 Underlying: Common Stock · 420.97 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 48.381 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:12 UTC |
Winkler LoriSVP and CHRO
|
SaleCommon Stock | 2,650 | $94.66 | $250,849.00 |
DisclosureSEC source: 0001852191-26-000010 · form4-03162026_080329.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,224 Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Upadhyay SuketuExec VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001533149-26-000009 · form4-03102026_080309.xml · derivative · entry 6 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,559 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Upadhyay SuketuExec VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 10,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001533149-26-000009 · form4-03102026_080309.xml · derivative · entry 5 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,217 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Upadhyay SuketuExec VP, CFO
|
Tax withholdingCommon Stock | 2,029 | $92.54 | $187,763.66 |
DisclosureSEC source: 0001533149-26-000009 · form4-03102026_080309.xml · nonDerivative · entry 4 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,485 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Upadhyay SuketuExec VP, CFO
|
Exercise / conversionCommon Stock | 4,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001533149-26-000009 · form4-03102026_080309.xml · nonDerivative · entry 3 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Upadhyay SuketuExec VP, CFO
|
Tax withholdingCommon Stock | 4,547 | $92.54 | $420,779.38 |
DisclosureSEC source: 0001533149-26-000009 · form4-03102026_080309.xml · nonDerivative · entry 2 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,955 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:13 UTC |
Upadhyay SuketuExec VP, CFO
|
Exercise / conversionCommon Stock | 10,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001533149-26-000009 · form4-03102026_080309.xml · nonDerivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:09 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionRestricted Stock Units · Derivative | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001864818-26-000008 · form4-03102026_080328.xml · derivative · entry 6 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,161 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:09 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionRestricted Stock Units · Derivative | 4,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001864818-26-000008 · form4-03102026_080328.xml · derivative · entry 5 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,843 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:09 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Tax withholdingCommon Stock | 562 | $92.54 | $52,007.48 |
DisclosureSEC source: 0001864818-26-000008 · form4-03102026_080328.xml · nonDerivative · entry 4 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,991 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:09 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionCommon Stock | 2,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001864818-26-000008 · form4-03102026_080328.xml · nonDerivative · entry 3 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:09 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Tax withholdingCommon Stock | 1,260 | $92.54 | $116,600.40 |
DisclosureSEC source: 0001864818-26-000008 · form4-03102026_080328.xml · nonDerivative · entry 2 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,392 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:09 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionCommon Stock | 4,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001864818-26-000008 · form4-03102026_080328.xml · nonDerivative · entry 1 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001852191-26-000008 · form4-03102026_080350.xml · derivative · entry 6 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,699 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001852191-26-000008 · form4-03102026_080350.xml · derivative · entry 5 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,935 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC |
Winkler LoriSVP and CHRO
|
Tax withholdingCommon Stock | 629 | $92.54 | $58,207.66 |
DisclosureSEC source: 0001852191-26-000008 · form4-03102026_080350.xml · nonDerivative · entry 4 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,874 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionCommon Stock | 1,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001852191-26-000008 · form4-03102026_080350.xml · nonDerivative · entry 3 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC |
Winkler LoriSVP and CHRO
|
Tax withholdingCommon Stock | 1,549 | $92.54 | $143,344.46 |
DisclosureSEC source: 0001852191-26-000008 · form4-03102026_080350.xml · nonDerivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,804 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionCommon Stock | 3,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001852191-26-000008 · form4-03102026_080350.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 2,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000010 · form4-03102026_080309.xml · derivative · entry 4 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,364 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 7,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000010 · form4-03102026_080309.xml · derivative · entry 3 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,050 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionCommon Stock | 2,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000010 · form4-03102026_080309.xml · nonDerivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionCommon Stock | 7,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000010 · form4-03102026_080309.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:07 UTC |
Stellato Paul AVP, Controller, CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 607 | $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000008 · form4-03102026_080329.xml · derivative · entry 6 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 607 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:07 UTC |
Stellato Paul AVP, Controller, CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000008 · form4-03102026_080329.xml · derivative · entry 5 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,363 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:07 UTC |
Stellato Paul AVP, Controller, CAO
|
Tax withholdingCommon Stock | 282 | $92.54 | $26,096.28 |
DisclosureSEC source: 0001714585-26-000008 · form4-03102026_080329.xml · nonDerivative · entry 4 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,582 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:07 UTC |
Stellato Paul AVP, Controller, CAO
|
Exercise / conversionCommon Stock | 607 | $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000008 · form4-03102026_080329.xml · nonDerivative · entry 3 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:07 UTC |
Stellato Paul AVP, Controller, CAO
|
Tax withholdingCommon Stock | 633 | $92.54 | $58,577.82 |
DisclosureSEC source: 0001714585-26-000008 · form4-03102026_080329.xml · nonDerivative · entry 2 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,257 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:07 UTC |
Stellato Paul AVP, Controller, CAO
|
Exercise / conversionCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000008 · form4-03102026_080329.xml · nonDerivative · entry 1 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 5,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · derivative · entry 9 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,438 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · derivative · entry 8 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,830 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 24,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · derivative · entry 7 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,436 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 3,008 | $92.54 | $278,360.32 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 6 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,191 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 5,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 5 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 2,671 | $92.54 | $247,174.34 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 4 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,761 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 4,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 13,516 | $92.54 | $1,250,770.64 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,602 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 24,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000008 · form4-03102026_080304.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC |
Phipps Chad FSee remarks below.
|
Exercise / conversionRestricted Stock Units · Derivative | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · derivative · entry 6 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,094 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC |
Phipps Chad FSee remarks below.
|
Exercise / conversionRestricted Stock Units · Derivative | 4,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · derivative · entry 5 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,692 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC |
Phipps Chad FSee remarks below.
|
Tax withholdingCommon Stock | 843 | $92.54 | $78,011.22 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · nonDerivative · entry 4 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,760 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.